These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36004650)
1. Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells. Xu Y; Zheng J; Ye ZY Neoplasma; 2022 Sep; 69(5):1119-1128. PubMed ID: 36004650 [TBL] [Abstract][Full Text] [Related]
2. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway. Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566 [TBL] [Abstract][Full Text] [Related]
3. [Ethoxysanguinarine directly targets CIP2A to inhibit proliferation and induce autophagy of SGC7901/DDP cells]. Wan F; Tan M; Xiang YC; Liu XW; Peng P; Liu Y Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5890-5899. PubMed ID: 36472008 [TBL] [Abstract][Full Text] [Related]
4. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades. Kim SM; Park JH; Kim KD; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS Phytother Res; 2014 Mar; 28(3):423-31. PubMed ID: 23686889 [TBL] [Abstract][Full Text] [Related]
5. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells. Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946 [TBL] [Abstract][Full Text] [Related]
6. Anlotinib Inhibits Proliferation and Induces Apoptosis in B-cell Acute Lymphoblastic Leukemia by Targeting the BTK and AKT/mTOR Pathway. Shi X; Li S; Tang S; Lu Y Anticancer Agents Med Chem; 2023; 23(12):1397-1405. PubMed ID: 36856175 [TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway. Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704 [TBL] [Abstract][Full Text] [Related]
8. Novel mechanism of napabucasin, a naturally derived furanonaphthoquinone: apoptosis and autophagy induction in lung cancer cells through direct targeting on Akt/mTOR proteins. Petsri K; Thongsom S; Racha S; Chamni S; Jindapol S; Kaekratoke N; Zou H; Chanvorachote P BMC Complement Med Ther; 2022 Sep; 22(1):250. PubMed ID: 36180880 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition effect of active fraction from clove on PI3K/Akt/mTOR signaling pathway to induce apoptosis of human colon cancer HCT116 cells]. Zhao G; Zhang D; Yang XH; Li XF; Liu MH Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(5):1197-1204. PubMed ID: 33787115 [TBL] [Abstract][Full Text] [Related]
10. Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway. Divakar S; Saravanan K; Karthikeyan P; Elancheran R; Kabilan S; Balasubramanian KK; Devi R; Kotoky J; Ramanathan M Chem Biol Interact; 2017 Sep; 275():22-34. PubMed ID: 28757136 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070 [TBL] [Abstract][Full Text] [Related]
12. Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis. Sugawara T; Nevedomskaya E; Heller S; Böhme A; Lesche R; von Ahsen O; Grünewald S; Nguyen HM; Corey E; Baumgart SJ; Georgi V; Pütter V; Fernández-Montalván A; Vasta JD; Robers MB; Politz O; Mumberg D; Haendler B Mol Oncol; 2024 Mar; 18(3):726-742. PubMed ID: 38225213 [TBL] [Abstract][Full Text] [Related]
13. Corn silk maysin induces apoptotic cell death in PC-3 prostate cancer cells via mitochondria-dependent pathway. Lee J; Lee S; Kim SL; Choi JW; Seo JY; Choi DJ; Park YI Life Sci; 2014 Dec; 119(1-2):47-55. PubMed ID: 25445226 [TBL] [Abstract][Full Text] [Related]
14. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells. Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001 [TBL] [Abstract][Full Text] [Related]
15. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
16. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
17. Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway. He C; Wu T; Hao Y Biochem Biophys Res Commun; 2018 Sep; 503(4):3093-3099. PubMed ID: 30146257 [TBL] [Abstract][Full Text] [Related]
18. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295 [TBL] [Abstract][Full Text] [Related]
20. Anti-cancer Drug Anlotinib Promotes Autophagy and Apoptosis in Breast Cancer. Chen S; Gao Y; Zhu P; Wang X; Zeng L; Jin Y; Zhi X; Yang H; Zhou P Front Biosci (Landmark Ed); 2022 Apr; 27(4):125. PubMed ID: 35468684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]